1-2 of 2
Jiangtao Ren, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yongxian Hu, MD, Yali Zhou, Mingming Zhang, MD, Wengang Ge, Yi Li, MD, Li Yang, MD, Guoqing Wei, MD, Lu Han, Hao Wang, Xingwang Zhang, PhD, Jiangtao Ren, PhD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 52.
https://doi.org/10.1182/blood-2020-142262
Published: 2020
Journal Articles

Multiplex Cripsr/Cas9 Genome Editing to Generate Potent Universal CART and PD1-Deficient Cells Against Leukemia

Jiangtao Ren, PhD, Xiaojun Liu, Master, Chongyun Fang, PhD, Shuguang Jiang, PhD, Carl H. June, MD, Yangbing Zhao, PhD MD
Journal: Blood
Blood (2015) 126 (23): 4280.
https://doi.org/10.1182/blood.V126.23.4280.4280
Published: 2015